Consistent with the model in which heterochromatin restricts access to proteins involved in DNA repair, treatment with the HDAC inhibitor trichostatin promoted euchromatin formation and increased DNA damage response in breast cancer cells [39]. The gene discussed is HDAC9; the disease is breast cancer.